Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
32
GBIO Quote, Financials, Valuation and Earnings
Last price:
$5.50
Seasonality move
:
-14.66%
Day range:
$5.46 - $5.64
52-week range:
$3.00 - $12.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.93x
P/B ratio:
0.74x
Volume:
20.1K
Avg. volume:
59.8K
1-year change:
-48.04%
Market cap:
$37.3M
Revenue:
$19.9M
EPS (TTM):
-$7.36
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $5.9M | $19.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 236.92% | |
| Cost of Revenues | $3.4M | $4.5M | $5.1M | $5.3M | $4.9M | |
| Gross Profit | -$3.4M | -$4.5M | -$5.1M | $641K | $15M | |
| Gross Profit Margin | -- | -- | -- | 10.86% | 75.21% | |
| R&D Expenses | $55.1M | $80.7M | $86.5M | $83.2M | $56.1M | |
| Selling, General & Admin | $22.6M | $33.9M | $44.5M | $50.9M | $37.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$63.2M | |
| Operating Expenses | $77.7M | $114.6M | $131M | $132.2M | $93.3M | |
| Operating Income | -$81.1M | -$119.1M | -$136.1M | -$131.5M | -$78.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$80.5M | -$119.2M | -$136.6M | -$126.6M | -$131.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$80.5M | -$119.2M | -$136.6M | -$126.6M | -$131.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$80.5M | -$119.2M | -$136.6M | -$126.6M | -$131.7M | |
| Basic EPS (Cont. Ops) | -$2.95 | -$2.12 | -$2.35 | -$1.96 | -$19.76 | |
| Diluted EPS (Cont. Ops) | -$2.95 | -$2.12 | -$2.35 | -$1.96 | -$19.76 | |
| Weighted Average Basic Share | $27.3M | $56.3M | $58.1M | $64.5M | $6.7M | |
| Weighted Average Diluted Share | $27.3M | $56.3M | $58.1M | $64.5M | $6.7M | |
| EBITDA | -$77.7M | -$114.6M | -$131M | -$126.3M | -$73.4M | |
| EBIT | -$81.1M | -$119.1M | -$136.1M | -$131.5M | -$78.3M | |
| Revenue (Reported) | -- | -- | -- | $5.9M | $19.9M | |
| Operating Income (Reported) | -$81.1M | -$119.1M | -$136.1M | -$131.5M | -$78.3M | |
| Operating Income (Adjusted) | -$81.1M | -$119.1M | -$136.1M | -$131.5M | -$78.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2.1M | $7.6M | $1.6M | |
| Revenue Growth (YoY) | -- | -- | -- | 252% | -78.9% | |
| Cost of Revenues | $1.2M | $1.4M | $1.3M | $1.2M | $1.4M | |
| Gross Profit | -$1.2M | -$1.4M | $853K | $6.4M | $190K | |
| Gross Profit Margin | -- | -- | 39.75% | 84.38% | 11.92% | |
| R&D Expenses | $20.8M | $19.5M | $20.6M | $13.9M | $14M | |
| Selling, General & Admin | $9.7M | $11.5M | $11.6M | $9.2M | $12.2M | |
| Other Inc / (Exp) | -- | -- | -- | -$1.2M | -- | |
| Operating Expenses | $30.5M | $30.9M | $32.2M | $23.1M | $21.7M | |
| Operating Income | -$31.7M | -$32.3M | -$31.4M | -$16.7M | -$21.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$31.9M | -$31.3M | -$28.3M | -$15.3M | -$5.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$31.9M | -$31.3M | -$28.3M | -$15.3M | -$5.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$31.9M | -$31.3M | -$28.3M | -$15.3M | -$5.5M | |
| Basic EPS (Cont. Ops) | -$0.56 | -$0.53 | -$0.43 | -$0.23 | -$0.82 | |
| Diluted EPS (Cont. Ops) | -$0.56 | -$0.53 | -$0.43 | -$0.23 | -$0.82 | |
| Weighted Average Basic Share | $56.6M | $58.9M | $65.9M | $66.7M | $6.7M | |
| Weighted Average Diluted Share | $56.6M | $58.9M | $65.9M | $66.7M | $6.7M | |
| EBITDA | -$30.5M | -$30.9M | -$30.1M | -$15.5M | -$20.1M | |
| EBIT | -$31.7M | -$32.3M | -$31.4M | -$16.7M | -$21.5M | |
| Revenue (Reported) | -- | -- | $2.1M | $7.6M | $1.6M | |
| Operating Income (Reported) | -$31.7M | -$32.3M | -$31.4M | -$16.7M | -$21.5M | |
| Operating Income (Adjusted) | -$31.7M | -$32.3M | -$31.4M | -$16.7M | -$21.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $3M | $18.6M | $15.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.4M | $4.9M | $5.3M | $5.1M | $4.9M | |
| Gross Profit | -$4.4M | -$4.9M | -$2.3M | $13.5M | $10.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $75.4M | $86.6M | $82.3M | $63.5M | $56.2M | |
| Selling, General & Admin | $32.7M | $40.5M | $50.6M | $42.5M | $37.3M | |
| Other Inc / (Exp) | -- | -- | -- | -$59.6M | -- | |
| Operating Expenses | $108.1M | $127.1M | $132.9M | $103.7M | $88.7M | |
| Operating Income | -$112.5M | -$132M | -$135.1M | -$90.2M | -$78.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$112.4M | -$135.2M | -$123.8M | -$145.5M | -$62.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$112.4M | -$135.2M | -$123.8M | -$145.5M | -$62.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$112.4M | -$135.2M | -$123.8M | -$145.5M | -$62.6M | |
| Basic EPS (Cont. Ops) | -$2.10 | -$2.35 | -$1.98 | -$2.19 | -$7.36 | |
| Diluted EPS (Cont. Ops) | -$2.10 | -$2.35 | -$1.98 | -$2.19 | -$7.36 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$108.1M | -$127.1M | -$129.8M | -$85.1M | -$73.4M | |
| EBIT | -$112.5M | -$132M | -$135.1M | -$90.2M | -$78.3M | |
| Revenue (Reported) | -- | -- | $3M | $18.6M | $15.3M | |
| Operating Income (Reported) | -$112.5M | -$132M | -$135.1M | -$90.2M | -$78.3M | |
| Operating Income (Adjusted) | -$112.5M | -$132M | -$135.1M | -$90.2M | -$78.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $3M | $15.7M | $11.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.4M | $3.8M | $3.9M | $3.8M | $3.7M | |
| Gross Profit | -$3.4M | -$3.8M | -$912K | $11.9M | $7.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $60M | $65.9M | $61.8M | $42.1M | $42.2M | |
| Selling, General & Admin | $24.8M | $31.4M | $37.5M | $29.1M | $28.7M | |
| Other Inc / (Exp) | -- | -- | -- | -$59.6M | -$1.1M | |
| Operating Expenses | $84.8M | $97.3M | $99.2M | $70.8M | $66.2M | |
| Operating Income | -$88.2M | -$101.1M | -$100.1M | -$58.8M | -$58.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$88.2M | -$104.2M | -$91.4M | -$110.3M | -$41.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$88.2M | -$104.2M | -$91.4M | -$110.3M | -$41.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$88.2M | -$104.2M | -$91.4M | -$110.3M | -$41.2M | |
| Basic EPS (Cont. Ops) | -$1.57 | -$1.81 | -$1.44 | -$1.66 | -$4.16 | |
| Diluted EPS (Cont. Ops) | -$1.57 | -$1.81 | -$1.44 | -$1.66 | -$4.16 | |
| Weighted Average Basic Share | $168.3M | $173M | $191.8M | $199.7M | $80.4M | |
| Weighted Average Diluted Share | $168.3M | $173M | $191.8M | $199.7M | $80.4M | |
| EBITDA | -$84.8M | -$97.3M | -$96.2M | -$55.1M | -$55.1M | |
| EBIT | -$88.2M | -$101.1M | -$100.1M | -$58.8M | -$58.8M | |
| Revenue (Reported) | -- | -- | $3M | $15.7M | $11.1M | |
| Operating Income (Reported) | -$88.2M | -$101.1M | -$100.1M | -$58.8M | -$58.8M | |
| Operating Income (Adjusted) | -$88.2M | -$101.1M | -$100.1M | -$58.8M | -$58.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $262.3M | $375.1M | $279.1M | $264.4M | $185.2M | |
| Short Term Investments | $199.4M | -- | $185.9M | $197.9M | $108.9M | |
| Accounts Receivable, Net | -- | -- | $395K | $4M | $1.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $5.4M | -- | $7M | $3.8M | $3.5M | |
| Other Current Assets | -- | $4M | $259K | $290K | $2.4M | |
| Total Current Assets | $267.7M | $379.2M | $287M | $272.6M | $192.9M | |
| Property Plant And Equipment | $23.8M | $91M | $81.4M | $95.7M | $35.6M | |
| Long-Term Investments | $2.1M | $5.7M | $5.7M | $5.8M | $2.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.3M | $6.1M | $7.4M | $6.4M | $2.6M | |
| Total Assets | $294.2M | $476.8M | $376.3M | $374.8M | $231.2M | |
| Accounts Payable | $267K | $2M | $662K | $2.3M | $1.4M | |
| Accrued Expenses | $3M | $3.9M | $3M | $2.9M | $1.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $4.6M | $7.1M | $8.1M | $13M | |
| Other Current Liabilities | $444K | $676K | $426K | $406K | $2.7M | |
| Total Current Liabilities | $11.2M | $18.8M | $19.2M | $39.9M | $35.1M | |
| Long-Term Debt | -- | $76.2M | $74.6M | $89.8M | $80.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $26.1M | $95M | $93.8M | $171.6M | $145M | |
| Common Stock | $5K | $6K | $6K | $7K | $7K | |
| Other Common Equity Adj | $9K | -- | -$83K | $274K | $159K | |
| Common Equity | $268M | $381.7M | $282.5M | $203.1M | $86.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $268M | $381.7M | $282.5M | $203.1M | $86.2M | |
| Total Liabilities and Equity | $294.2M | $476.8M | $376.3M | $374.8M | $231.2M | |
| Cash and Short Terms | $262.3M | $375.1M | $279.1M | $264.4M | $185.2M | |
| Total Debt | -- | $76.2M | $74.6M | $89.8M | $80.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $398.4M | $301.2M | $291M | $184.8M | $89.6M | |
| Short Term Investments | $10M | $166.7M | $197.7M | $163.1M | -- | |
| Accounts Receivable, Net | -- | $395K | $660K | $2.2M | $391K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $4.9M | $9M | -- | -- | -- | |
| Other Current Assets | -- | -- | $6.1M | $4.3M | -- | |
| Total Current Assets | $403.3M | $310.6M | $297.8M | $191.3M | $93.5M | |
| Property Plant And Equipment | $54.2M | $84.6M | $76.8M | $37.2M | $26.3M | |
| Long-Term Investments | $5.7M | $5.7M | $5.7M | $17.2M | $2.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.1M | $7.2M | $6.5M | $5.3M | -- | |
| Total Assets | $464M | $402.8M | $381.5M | $248.8M | $121.9M | |
| Accounts Payable | $520K | $1.7M | $2.7M | $1.7M | $2.1M | |
| Accrued Expenses | $3.7M | $2.2M | $3.3M | $1.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.4M | $6.6M | $8.7M | $10.8M | -- | |
| Other Current Liabilities | $740K | $370K | $370K | $405K | -- | |
| Total Current Liabilities | $14.5M | $17.3M | $32.8M | $30.2M | $21M | |
| Long-Term Debt | $42.3M | $76.7M | $71M | $83M | $19.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $56.8M | $94.1M | $149.6M | $144.3M | $71.3M | |
| Common Stock | $6K | $6K | $7K | $7K | $1K | |
| Other Common Equity Adj | -- | -$302K | -$4K | $319K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $407.2M | $308.7M | $231.9M | $104.4M | $50.6M | |
| Total Liabilities and Equity | $464M | $402.8M | $381.5M | $248.8M | $121.9M | |
| Cash and Short Terms | $398.4M | $301.2M | $291M | $184.8M | $89.6M | |
| Total Debt | $42.3M | $76.7M | $71M | $83M | $19.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$80.5M | -$119.2M | -$136.6M | -$126.6M | -$131.7M | |
| Depreciation & Amoritzation | $3.4M | $4.5M | $5.1M | $5.3M | $4.9M | |
| Stock-Based Compensation | $8.4M | $17.9M | $24.5M | $24.3M | $14.6M | |
| Change in Accounts Receivable | $448K | -- | -$395K | -$3.6M | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$70.1M | -$91.8M | -$102.4M | -$52.7M | -$88.6M | |
| Capital Expenditures | $5.5M | $6M | $8.8M | $7.4M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$205.2M | $193M | -$192.5M | -$9.7M | $94.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.2M | -$955K | $11.7M | -$729K | -$186K | |
| Cash From Financing | $323.1M | $214.7M | $13M | $35.8M | $250K | |
| Beginning Cash (CF) | $62.9M | $375.1M | $93.2M | $66.4M | $76.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $47.8M | $315.9M | -$282M | -$26.6M | $6.2M | |
| Ending Cash (CF) | $110.6M | $691M | -$188.8M | $39.8M | $82.5M | |
| Levered Free Cash Flow | -$75.7M | -$97.8M | -$111.2M | -$60.1M | -$91M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$31.9M | -$31.3M | -$28.3M | -$15.3M | -$5.5M | |
| Depreciation & Amoritzation | $1.2M | $1.4M | $1.3M | $1.2M | $1.4M | |
| Stock-Based Compensation | $5M | $5.8M | $6M | $3.8M | $2M | |
| Change in Accounts Receivable | -- | $1.4M | -$320K | -$875K | -$135K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$22.9M | -$20.5M | -$24.9M | -$19.5M | -$52.7M | |
| Capital Expenditures | $940K | $651K | $610K | $91K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $22.2M | -$12.6M | -$26.6M | $12.7M | $25.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$392K | -$394K | -$131K | -$16K | -- | |
| Cash From Financing | $698K | $9.3M | -$131K | -$3K | -$2K | |
| Beginning Cash (CF) | $388.3M | $134.5M | $93.4M | $21.7M | $21.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$84K | -$23.8M | -$51.6M | -$6.8M | -$27.2M | |
| Ending Cash (CF) | $388.3M | $110.7M | $41.8M | $14.8M | -$5.2M | |
| Levered Free Cash Flow | -$23.9M | -$21.1M | -$25.5M | -$19.6M | -$52.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$112.4M | -$135.2M | -$123.8M | -$145.5M | -$62.6M | |
| Depreciation & Amoritzation | $4.4M | $4.9M | $5.3M | $5.1M | $4.9M | |
| Stock-Based Compensation | $16.2M | $23.6M | $24.1M | $17.5M | $8.8M | |
| Change in Accounts Receivable | -- | -- | -$265K | -$5.5M | $1.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$90.3M | -$99.3M | -$50.8M | -$97.8M | -$113.7M | |
| Capital Expenditures | $4.9M | $11M | $3.5M | $6.6M | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $206.2M | -$167M | -$26.2M | $22.3M | $113.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$983K | -$457K | $11.5M | -$274K | -- | |
| Cash From Financing | $217.5M | $12.4M | $35.8M | $183K | $215K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $333.4M | -$253.9M | -$41.1M | -$75.2M | $283K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$95.2M | -$110.3M | -$54.3M | -$104.4M | -$114.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$88.2M | -$104.2M | -$91.4M | -$110.3M | -$41.2M | |
| Depreciation & Amoritzation | $3.4M | $3.8M | $3.9M | $3.8M | $3.7M | |
| Stock-Based Compensation | $12.8M | $18.6M | $18.3M | $11.4M | $5.7M | |
| Change in Accounts Receivable | -- | $1.4M | -$265K | -$2.2M | $833K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$72M | -$79.4M | -$27.8M | -$72.8M | -$97.9M | |
| Capital Expenditures | $3.1M | $8.1M | $2.8M | $2M | $705K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $185.9M | -$174.1M | -$7.8M | $24.2M | $43.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$942K | -$444K | -$627K | -$172K | -$7K | |
| Cash From Financing | $215.2M | $12.9M | $35.7M | $106K | $71K | |
| Beginning Cash (CF) | $1.1B | $629.7M | $334M | $87.9M | $121.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $329.1M | -$240.7M | $189K | -$48.4M | -$54.4M | |
| Ending Cash (CF) | $1.5B | $389.1M | $334.2M | $39.4M | $67.6M | |
| Levered Free Cash Flow | -$75.1M | -$87.6M | -$30.6M | -$74.8M | -$98.6M | |
Related Companies
Get GBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBIO
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
0.74x
1.82x
Price / LTM sales
7.93x
1.60x
Growth Metrics
GBIO
Sector
Revenue growth
-78.9%
4.62%
Earnings growth
-257.24%
10.88%
Revenue (5-year growth)
177.31%
6.5%
Earnings forecast
-$3.00
-$0.21
Profitability
GBIO
Sector
Profitability FY 2024
$15M
$3.5M
Return on invested capital
-41.48%
-31.77%
Return on assets
-31.87%
-27.96%
Return on equity
-84.94%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
4
Balance Sheet
GBIO
Sector
Total cash
$89.6M
$26.3M
Short term investments
$108.9M
$25.7M
Total assets
$231.2M
$78M
Long term debt
$19.7M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.51% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.27% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 6.84% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
